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Abstract
Cutaneous biopsy is a complementary method, alternative to peripheral nerve
biopsy, for the analysis of nerve involvement in peripheral neuropathies, systemic
diseases, and several pathologies of the central nervous system. Most of these
neuropathological studies were focused on the intraepithelial nerve fibers (thin-
myelinated Aδ fibers and unmyelinated C fibers), and few studies investigated the
variations in dermal innervation, that is, large myelinated fibers, Merkel’s cell-
neurite complexes, and Meissner’s corpuscles. Here, we updated and summarized
the current data about the quantitative and qualitative changes that undergo MCs
and MkCs in peripheral neuropathies. Moreover, we provide a comprehensive
rationale to include MCs in the study of cutaneous biopsies when analyzing the
peripheral neuropathies and aim to provide a protocol to study them.
Keywords: skin biopsy, peripheral neuropathy, Meissner’s corpuscles,
Merkel’s cells
1. Introduction
Since the last half of the past century, the analysis in the cutaneous biopsy of
nerves, Merkel’s cells (MkCs), and sensory corpuscles, especially Meissner’s cor-
puscles (MCs), become a complementary method to diagnose peripheral neuropa-
thies [1] and a reliable alternative to peripheral nerve biopsy. Nevertheless, it has
been during the last decade that numerous studies have provided consistent evi-
dence to support this technique as a valuable tool to understand the etiologies of
some neurological diseases and to follow up clinical trials [2–4] (Figures 1 and 2).
Most of the neuropathological studies on cutaneous biopsies were focused on
intraepithelial nerve fibers, which are thin-myelinated Aδ fibers or unmyelinated C
fibers [2, 3, 5–9]. Conversely, few studies have investigated the large myelinated fibers
(although it can offer notable advantages over the unmyelinated ones [10]). Also, the
quantitative and qualitatively changes in MCs and MkCs associated to peripheral
neuropathies are poorly known although the study of MCs has gained interest [11–13].
1
The evaluation of the dermal innervation, including large fibers, MCs, and
MkCs, is not currently included within the routine analysis of skin biopsies because
of the lack of a validated protocol. Changes in the density and size of MC and MkCs
(i.e., variations in number/unit of surface, atrophy and/or hypertrophy, protein
expression, etc.), can reflect quantitative or qualitative variations in the number of
sensory neurons or nerve fibers innervating them or in the cells forming MCs
themselves. Even more, they might also reflect pathologies of the central nervous
system, and in these cases, the cutaneous biopsy becomes a method to study dis-
eases difficult to be analyzed without invasive surgery.
This chapter is aimed to update the current data about the quantitative and
qualitative changes in MCs and MkCs in peripheral neuropathies, as well as to
provide a comprehensive rationale to include them in the study of cutaneous biop-
sies when analyzing the peripheral neuropathies. Furthermore, our purpose is to
provide a technical protocol for analyzing MCs and MkCs in cutaneous biopsies. We
have excluded from this review the intraepidermic nerve fibers because they have
been extensively studied in peripheral neuropathies, and standardized method has
been proposed and accepted [4, 9].
2. State of the art: a review and update of the literature
2.1 Why do we study Meissner’s corpuscles and Merkel’s cells for clinical
purposes
The cutaneous MCs are sensory structures placed just beneath the epidermis
within the dermal papillae in areas especially sensitive to light touch, like the finger-
tips, palms, soles, lips, and male and female genital skin [14–16]. They show an
ellipsoid morphology with the main axis perpendicular to the skin surface and a size
largely variable (length of 80–150 μm and diameter of 20–40 μm). Structurally, they
consist of an axon that runs between the stacked nonmyelinating Schwann-like cells
(the so-called lamellar cells) and habitually lacks a differentiated capsule [14, 16, 17].
Figure 1.
Meissner’s corpuscles (arrows) and Merkel’s cells in the first toe skin of nondiabetic (nd) and diabetic (d)
subjects as observed using immunohistochemistry for S100 protein (S100P) and cytokeratin-20 (CK20),
specific markers for lamellar cells and Merkel’s cells, respectively.
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MCs are particularly abundant in the fingers and palm hand, which are two
zones easily accessible for biopsy. Nevertheless, the analysis of MCs from these
zones has many problems. First of all, the normal density (MCs/mm2) at this
localization should be determined to compare normal and pathological conditions.
The most ancient studies established that the density of MCs in the human hand is
10–24 MCs/mm2 [18–20], it is higher in the fingertip (2.7/mm2  0.68) than in
the palm (1.33/mm2  0.6), and it does not change significantly with age [21].
Nolano et al. [22] found 33.02/mm2  13.2 in the fingertip of digit III and 45/mm2 in
the digit V; Herrmann et al. [12] determined that the density of MCs on the palmar
side of digit V is 12/mm2  5.3, whereas in the skin of the thenar eminence, it is
5.1/mm2  2.2.
The second trouble for the use of MCs in the diagnosis of neuropathies is
whether or not MCs change in density and characteristic with aging. A reduction in
number and size of MCs in elderly is generally assumed [18, 23–25], but detailed
studies are not available. Preliminary data from our laboratory demonstrate that
aging is accomplished of a reduction in the number and size of digital MCs, as well
as changes in their architecture and immunohistochemical properties (García-
Piqueras et al., unpublished). However, the variations in the corpuscular size and
morphology of MCs are difficult to evaluate because of their large variability within
the same skin sample. Therefore, in the absence of evident atrophy, hypertrophy, or
Figure 2.
Meissner’s corpuscles (arrows) of the palmar aspect of the fingers of patients diagnosed of Alzheimer’s disease,
amyotrophic lateral sclerosis, and multiple sclerosis, as observed using immunohistochemistry for S100 protein
(S100P). The samples were obtained during necropsy and in compliance with Spanish law.
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corpuscular disruption, the evaluation of these parameters must be cautiously con-
sidered when evaluating cutaneous biopsies.
The main constituents of MCs, that is, the axon and lamellar cells, contain specific
proteins as widely demonstrated using immunohistochemistry [17, 26, 27]. These
studies reported a large volume of information, but they are purely descriptive and do
not consent to quantify those proteins and their possible variations in neuropathies.
The central axon displays immunoreactivity for general neuronal markers (neuron-
specific enolase, protein gene product 9.5, neurofilament subunit proteins). They also
express Ca2+-binding proteins such as calbindin D28k, parvalbumin, calretinin, and
neurocalcin, which presumably regulate the axonic Ca2+ homeostasis and therefore
participate in the mechanoelectric transduction. Recently, our research’s group
detected axonic TRPC6, TRPV4, ASIC2, and Piezo2 ion channels that work as puta-
tive mechanoproteins [28–30]. Regarding lamellar cells, the vimentin is the interme-
diate filament filling their cytoplasm, while the glial fibrillary acidic protein is always
absent. They strongly express S100 protein colocated with parvalbumin or calbindin
D-28 kDa. The lamellar cells also display immunoreactivity for TrkB, the signaling
receptor for the neurotrophins BDNF/NT-4 [31]. Apart from axon- or lamellar cell-
specific proteins, there are some others shared by both corpuscular constituents. They
include p75NTR and TrkA (low-affinity pan-neurotrophin receptor and the high-
affinity receptor for nerve growth factor, respectively; [32, 33]), the epidermal
growth factor receptor [34], or cell death protein Bcl-2 [35]. The presence of some ion
channels in the lamellar cells has been also reported [28–30]. It is possible that some
of these proteins undergo changes during peripheral neuropathies, but limited infor-
mation is so far available in this topic (see [17]). The proteins present in human MCs
are summarized in Table 1.
The cutaneous MkCs are special epidermal cells placed in the basal layer of the
epidermis, isolated or forming clusters, in both the glabrous and hairy skin. They
are innervated by Aβ sensory axons connected through synapse-like contacts
forming the so-called MkCs-neurite complexes. MkCs are involved in fine touch
working as a part of slowly adapting type I low-threshold mechanoreceptors and
express specific mechanoproteins [16, 30, 36–39]. MkCs have an epithelial origin
and do not originate from the neural crest, as classically accepted [40–42].
Using immunohistochemistry, diverse proteins have been detected in the MkC-
neurite complexes. They include low-molecular-weight cytokeratins and a reper-
tory of synaptic vesicles-related proteins (chromogranin A, synaptophysin), differ-
ent neuropeptides as well as neurotransmitter receptors, neurotrophin receptors,
ion channels (ASIC2 and Piezo2), and neuron-specific enolase [28, 43–46]. The
axon of the MkC-neurite complexes displays immunoreactivity for general neuronal
markers (Table 1).
The density of MCs varies from an anatomical region to another, and it is directly
related to the sensibility of those zones [47]. In terms of density as far as we know, no
age-dependent changes have been communicated. Recently, we have found signifi-
cant reduction in of digital MkCs with aging (García-Piqueras et al., unpublished).
On the other hand, whether or not MkCs, or the nerve fibers innervating them, are
involved in peripheral neuropathies has been poorly studied, but this possibility
should be explored because the easily accessibility to MkCs-neurite complexes.
2.2 Variations in MCs and MKCs in peripheral neuropathies
Data reporting changes in MCs in peripheral neuropathies are scarce and are
restricted to diabetes and other rare inheretary neuropathies, HIV infection,
mechanical or traumatic nerve entrapment, and a miscellaneous group of systemic
diseases with neurological symptoms.
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Meissner’s corpuscles Merkel’s cell-neurite
complex
Protein Ax LC Ax MC
Axonal proteins
Neuron-specific enolase
Protein gene product 9.5
β-Arrestin 1
GAP-43
Ca2+-binding proteins
S100 protein
Calbindin D28K
Calretinin
Neurocalcin
Cytoskeletal proteins
Neurofilament proteins
Vimentin
Growth factor receptors
p75NTR (pan-neurotrophin receptor)
TrkA (NGF receptor)
TrkB (BDNF/NT4 receptor)
EGF receptor
Putative mechanoproteins (ion channels)
ASIC2
Piezo2
TRPC6
TRPV4
TRPM8
Cell death-live proteins
Bcl-2
Neuropeptides and bioactive amines
Serotonin
Bombesin
Vasoactive intestinal polypeptide
Substance P
CCK8
Calcitonin gene-related peptide
Neuropeptide receptors
NMDA
Synaptic vesicle-associated proteins
Chromogranin A
Synaptophysin
Table 1.
Proteins detected in human Meissner’s corpuscles and Merkel’s cell neurite complexes using
immunohistochemistry. Red: positivity for a protein in the axon of Meissner's corpuscles; Blue: positivty for a
protein in the lamellar cells (LC) of Meissner's corpuscles.
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2.2.1 Diabetic neuropathy
Distal symmetric peripheral neuropathy is one of the most common complica-
tions of diabetes [48] and involves motor, autonomic, and sensory nerve fibers. The
histopathological studies have provided evidence that both the thin unmyelinated C
fibers and the large myelinated ones are affected in on diabetic neuropathy. Con-
sistently, the two most prominent complaints are peripheral pain and changes in
touch [13, 49–52]. The intraepidermic nerve fibers as well as the nerve apparatus of
the dermis are reduced in the diabetic neuropathy, and the reduction of the dermic
nerves involves MCs. Importantly, although some authors have argued their inter-
est in studying MCs and MkCs to better understand the diabetic neuropathy [53],
only few studies have approached this topic.
In cutaneous biopsies, it was shown that the density of MCs is significantly
reduced in diabetic patients with respect to the controls (10.2  8.4 vs.
16.2 9.4/mm2, more evidently in type I than in type II diabetes), and this correlated
with a reduction inmedian and ulnar nerves sensory amplitude; moreover, someMCs
were hypertrophic or showed anomalies in their architecture (disorganization of the
lamellar cells and increase in the irregularity of the axons) [54]. Similar findings as
those obtained from cutaneous biopsy were observed using in vivo reflectance confo-
cal microscopy at the thenar eminence and digit V [55]. We have recently communi-
cated that long-term diabetic neuropathy courses with a reduction in the number
and size of MCs and changes in their immunohistochemical profile [56] (Figure 1).
Nevertheless, the number and size of MCs are probably related with the time of
evolution of the neuropathy. In fact, in an animal model of diabetes that develop
neuropathy, MCs were found more abundant and hypertrophic during the first few
years of hyperglycemia, whereas after a long time, the hypertrophy declines but the
number of corpuscles remained higher than in age-matched nondiabetic subjects;
furthermore, the MCs from the diabetic animals found had abnormal structure and
immunochemistry properties [57].
On the other hand, as far as we know, the only study reporting a reduction in the
number of immunohistochemically demonstrable MkCs in diabetic neuropathy was
from our laboratory [56].
2.2.2 Charcot-Marie-Tooth disease
Charcot-Marie-Tooth (CMT) disease is a common inherited neuromuscular dis-
order characterized by neuropathies without known metabolic alterations. In the
skin of patients with common and rare forms of CMT caused by different muta-
tions, the density of MCs is reduced compared with normal controls [58–60].
Similar findings were reported by Almodovar et al. [61] using in vivo reflectance
confocal microscopy.
2.2.3 Human immunodeficiency virus (HIV) neuropathy
HIV-sensory neuropathy is a common complication of HIV infection and may be
associated with significant morbidity due to neuropathic pain [62]. Several
approaches exist for quantitative assessment of human HIV-associated distal sen-
sory polyneuropathy, and some of them have analyzed both unmyelinated and
myelinated nerve fibers, as well as MCs. Using in vivo reflectance confocal micros-
copy, it was found a marked reduction in MCs [12, 63] in HIV+ subjects with and
without distal sensory neuropathy [64].
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2.2.4 Entrapment neuropathies
Surprisingly, little is known about the impact of entrapment neuropathy on
target innervation. More than 20 years ago, we reported that human digital MCs
survive to entrapment or section of peripheral nerves for more than 10 years, and
although its number remains relatively stable, denervated MCs lack some antigens
or change the pattern of expression of some others [65–67]. These data were con-
firmed recently in subjects undergoing carpal tunnel syndrome [68].
2.2.5 Miscellaneous
A reduction in density or loss of MCs has also been reported in the skin of
patients suffering from Ross syndrome (a rare disorder of sweating associated with
areflexia and tonic pupil) [69], POEMS syndrome (polyneuropathy, organomegaly,
endocrinopathy, monoclonal gammopathy, and skin changes) [70], systemic scle-
rosis [71], pachyonychia congenita (in contrast, MkC densities are higher) [72],
chronic inflammatory demyelinating polyradiculoneuropathy [73], and systemic
lupus erythematosus [12].
2.3 MCs are also altered in central nervous system disorders
In addition to the abovementioned peripheral neuropathies, changes in MCs
have been reported in Parkinson’s disease associated or not with dementia [74–76],
spinobulbar muscular atrophy [77], Friedreich’s ataxia [78], amyotrophic lateral
sclerosis [79], or Guillain-Barré syndrome [73]. Furthermore, altered cutaneous
innervation also has been observed in some psychiatric disorders [80] and mental
deficiencies [81] (Figure 2).
3. Proposal of a method to systematically study MCs and MkCs in
cutaneous biopsies
MCs are only present in glabrous skin, and therefore fingers or toes are appro-
priate regions to take cutaneous biopsies focused to evaluate them; in spite of the
discrepancies regarding their density in these places, they are abundant enough.
In our opinion, the palmar aspect of fingertip IV would be an ideal region to be
biopsied, because it is not involved in handling; the lateral borders should be
excluded to avoid damaging the digital nerves and the formation of neuromas. On
the other hand, toe pad biopsies can be also useful, but they contain a lower density
of MCs than fingers [82].
The Joint Task Force EFNS/PNS [9] recommends to perform a 3 mm punch skin
biopsy (including epidermis and the subpapillary and reticular dermis), using a
sterile technique and under local anesthesia. A sample of these dimensions does not
need sutures, heal completely within 1 week, and this normally guaranties no side
effects or complaints. Informed consent is required, and information on the possible
risks must be always provided. The fixation of the skin samples is recommended in
2% PLP (2% paraformaldehyde, 0.075 M lysine, 0.037 M sodium phosphate, 0.01 M
periodate) or Zamboni’s solution. We have also obtained excellent structural results
and good antigen preservation using Bouin’s fixative and buffered 10% formalde-
hyde. Conversely, 4% paraformaldehyde masked most of the antigens present in
MCs. The thickness of the sections is also important. The Joint Task Force EFNS/
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PNS especially recommends 50-μm thick sections to perform 3D reconstructions of
MCs. Nevertheless, our experience demonstrates that to demonstrate the occur-
rence of most antigens present in the axon or in the lamellar cells of Meissner’s
corpuscles, 8 or 10 μm sections are appropriate.
There are different techniques for identification and assessment of MCs (silver
impregnation techniques, electron microscopy, immunohistochemistry, and immu-
nofluorescence), but the ideal one should allow to the quantification and specific
immunostaining, distinguishing the different MCs constituents. In routine studies,
at least one marker for the axon and one for the lamellar cells should be used.
Indirect immunofluorescence, especially when associated with confocal micros-
copy, provides an opportunity to investigate multiple neuronal and nonneuronal
proteins within the same MC and also to perform its 3D reconstruction using
appropriate computerized image analysis systems. Ideally, double immunostaining
for both axon and lamellar cells, associated or not with labeling of the nuclei,
provides a global image of the morphology and size of the corpuscle, as well as of
the arrangement of corpuscular constituents (Figure 3).
To quantify MCs, we use the method proposed by Verendeev et al. [83] to
establish the density of MCs in the fingertips of primates. Briefly, 10-μm-thick
sections, 200 μm apart, processed for S100 protein immunohistochemistry, are
used. The sections are scanned by SCN400F scanner (Leica, Leica Biosystems™)
and computerized using SlidePath Gateway LAN software (Leica, Leica
Biosystems™). Then, in each section, MCs are identified and counted by two
independent observers. The average numerical values were corrected applying
the Abercrombie’s formula: N = n*T/(T + H), where N is the corrected average
number of MCs, n is the counted average number of MCs in all sections of a
fingertip, T is the average section’s thickness, and H is the average diameter of the
counted MCs. Through a specific tool of the abovementioned software, the aver-
age MCs diameter was determinate measuring the horizontal axis by drawing a
straight line approximately in the central region of each corpuscle. The longitu-
dinal epidermis of each section (mm) is measured with the same tool, and the
average length was multiplied by the section’s thickness (mm) to give the mea-
sured surface area (mm2). Finally, the average number of Meissner corpuscles
(N) was divided by the surface area (mm2) that is the density of MCs by squared
millimeter of skin (number of MCs/mm2) (Figure 4). To establish the density of
digital Merkel’s cells, we used the same method immunostaining Merkel’s cells for
cytokeratin.
Figure 3.
3D reconstruction of a Meissner’s corpuscle in a finger of a 25-year-old male. The axon is labeled in red, and the
lamellar cells in green. The cell nuclei were labeled with DAPI. Scale bar = 20 μm.
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4. Final remarks and future prospectives
Peripheral neuropathies are diverse and require a multidimensional approach for
detection and monitoring clinical and research setting. The minimal invasiveness of
skin biopsy makes it a useful tool not only for diagnostics but also for following the
progression or the effects of a treatment in neuropathies.
Pathophysiological studies in patients with large nerve fiber polyneuropathies
are limited because the difficulty in obtaining nerve samples due to the invasive
nature of the procedure. For this reason, some authors utilized skin biopsies to
obtain morphological and molecular information from large dermal myelinated
nerve fibers. The development of new methods to evaluate skin innervation,
including MCs, through noninvasive techniques, that is, in vivo reflectance confocal
microscopy, may contribute to better understand the changes in sensory corpuscles
in neuropathies [12, 55, 61, 84–86].
Nevertheless, to use MCs as a complementary method in the diagnosis of neu-
rological diseases, more studies are still necessary. Firstly, the density of MCs must
be mapped in the specific areas where they are abundant and easily accessible to
cutaneous biopsy, especially the hand glabrous skin. Secondly, the physiological
age-related changes in the number and protein composition of MCs of these
selected areas must be established. Quantitative data, apart from qualitative, on
Figure 4.
Schematic representation of the technical procedure to quantify Meissner’s corpuscles in sections of human
digital skin immunostained for the detection of S100 protein.
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changes in protein composition of MCs with aging are necessary as a baseline for
possible pathological changes. In addition to immunohistochemical studies, skin
biopsy is amenable to the extraction of mRNA, RT-PCR, or microarrays for genes
involved in neuropathies, and these methods should be used and standardized to
study MCs. Finally, future studies should include not only neuropathies such as
neurofibromatosis [85], or other rare metabolic neuropathies such as Gaucher
type 1 disease [86], but also central nervous system diseases such as Alzheimer’s
disease.
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